SPARTA™ is a comprehensive nanoparticle analysis platform based on Raman spectroscopy providing simultaneous size, composition, and functionalisation analysis, as well as allowing live monitoring of dynamic reactions occurring on the surface of individual particles.
A novel multi-zonal anisotropic osteochondral scaffold has been developed which mimics the natural structure of articular cartilage with zone specific mechanical and biological properties
The present invention relates to a novel DNA delivery vector for targeted gene therapy, medical imaging and vaccination with increased efficacy over existing technologies. The platform comprises a phagemid hybrid with phage and recombinant adeno-associated virus (AAV) components.
A novel viral delivery vector with scope for more cost-effective commercial production over existing technologies. The platform comprises a phagemid hybrid with recombinant adeno-associated virus (AAV) components.
Researchers at Imperial College London have developed two novel modifications of bacteriophages to significantly improve their efficacy as vectors for targeted gene therapy, and exploit their advantages over eukaryotic viral vectors.
Suite of microRNAs for predicting cervical shortening and preterm birth that can be measured from blood samples taken in early pregnancy (from gestation week 12 onwards).
Novel truncated fragments of von Willebrand factor (VWF) engineered by a team at Imperial College London.
A fully flexible, scalable and low-cost detection platform to sense multiple protein targets simultaneously by grafting specific sequences along the backbone of a double-stranded DNA carrier.
Enables the production of lightweight but tough and damage tolerant structures
Over 3x energy saved vs standard wireless IoT sensor implementations.